New Labs and offices at Medicon Village
Iconovo has moved into new labs and offices at Medicon Village. We have now doubled our space and have several specialized labs and equipment for dry powder…
Investment in formulation development
Iconovo has raised 2.3 million EUR to expand the in-house development capacity. We will now be able to offer a comprehensive product development including…
Dry Powder Inhalers in London
Iconovo CEO Dr. Orest Lastow will be giving a speach at Dry Powder Inhalers Conference 27-28 July in London. The title of the speach is "How to develop…
Iconovo at RDD in Nice
Iconovo will be joining RDD Europe 2017 in Nice next week. Iconovo's participation was made possible by the kind support from the EU financed SSGG …
New employees at Iconovo
We welcome our two new associates: Richard Johnson and Fredrik Gunnarsson. Richard is a Mechanical Engineer and Fredrik is an Analytical Chemist.
Iconovo exhibiting at DDL 2016
Iconovo was a Bronze sponsor of DDL in Edinburgh. The sponsorship was in cooperation with EU financed SSGG project.
Dr Mikael Arinder joins Iconovo
Dr Mikael Arinder is Iconovo's new Vice President Operations. Mikael has a PhD. in organic chemistry and has long experience from the pharmaceutical industry…
Iconovo enters into licensing and product development with Amneal Pharmaceuticals
Iconovo has signed an agreement for a licensing deal and a product development project with Amneal Pharmaceuticals that produce and market generic drug…
Iconovo receives grant from Sweden’s innovation agency
Iconovo has received a 350 000 USD grant from Sweden’s innovation agency Vinnova. The development project includes optimization of ICOone and adaptation…
Iconovo to develop novel inhaled drug formulations together with University of Copenhagen
Iconovo has signed a development agreement with Copenhagen University. Iconovo's unit-dose inhaler ICOone will be used in two PhD projects investigating…
